Ipsen Biopharm Limited

Great Britain (UK) · Reporting entity ID 100000010586

Total reported 2019–2025

$513K

#1,559 of 2,960 reporting companies — 0% of all reported industry payments

$140K in general payments across 38 records, plus $373K in research funding across 1 records.

How it breaks down

General payments $140,366

Research funding $372,846

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.